DNTH
USDDianthus Therapeutics Inc. Common Stock
$33.200-0.690 (-2.036%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$33.890
High
$34.110
Low
$32.960
Volume
0.43M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.69M
Exchange
NCM
Currency
USD
52-Week Range
Low $13.37Current $33.200High $40.16
Related News
GlobeNewswire
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing Phase 3 gMG trial planned
View more
Analyst Upgrades
Truist Securities Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $56
Truist Securities analyst Danielle Brill initiates coverage on Dianthus Therapeutics with a Buy rating and announces Price Target of $56.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.